Criticism mounts of India's 'abrupt' approval of local vaccine

Criticism of India's approval of a local Covid-19 vaccine without proof of its efficacy grew on Wednesday after news that a regulatory panel approved the shot just one day after asking the vaccine maker for more evidence it would work.

The recommendations of the Indian drugs regulator's Subject Expert Committee (SEC) released on Tuesday show that the panel asked Bharat Biotech International Ltd to present more efficacy data for its Covid-19 shot before it could consider approving the treatment...